161 related articles for article (PubMed ID: 33116489)
1. The Use of Near-Infrared Light-Emitting Fluorescent Nanodiamond Particles to Detect Ebola Virus Glycoprotein: Technology Development and Proof of Principle.
Feuerstein GZ; Mansfield MA; Lelkes PI; Alesci S; Marcinkiewicz C; Butlin N; Sternberg M
Int J Nanomedicine; 2020; 15():7583-7599. PubMed ID: 33116489
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility studies of fluorescent diamond particles-(NV)~800nm (part V): in vitro kinetics and in vivo localization in rat liver following long-term exposure.
Gerstenhaber JA; Marcinkiewicz C; Barone FC; Sternberg M; D'Andrea MR; Lelkes PI; Feuerstein GZ
Int J Nanomedicine; 2019; 14():6451-6464. PubMed ID: 31496697
[TBL] [Abstract][Full Text] [Related]
3. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor.
Yu JS; Liao HX; Gerdon AE; Huffman B; Scearce RM; McAdams M; Alam SM; Popernack PM; Sullivan NJ; Wright D; Cliffel DE; Nabel GJ; Haynes BF
J Virol Methods; 2006 Nov; 137(2):219-28. PubMed ID: 16857271
[TBL] [Abstract][Full Text] [Related]
4. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM
J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622
[TBL] [Abstract][Full Text] [Related]
5. Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV).
Barone FC; Marcinkiewicz C; Li J; Feng Y; Sternberg M; Lelkes PI; Rosenbaum-Halevi D; Gerstenhaber JA; Feuerstein GZ
Int J Nanomedicine; 2019; 14():1163-1175. PubMed ID: 30863052
[TBL] [Abstract][Full Text] [Related]
6. Anti-Ebola MAb 17A3 reacts with bovine and human alpha-2-macroglobulin proteins.
Yu JS; Ma BJ; Scearce RM; Liao HX; Haynes BF
J Virol Methods; 2010 Sep; 168(1-2):248-50. PubMed ID: 20447422
[TBL] [Abstract][Full Text] [Related]
7. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus.
Lucht A; Grunow R; Otterbein C; Möller P; Feldmann H; Becker S
Med Microbiol Immunol; 2004 Nov; 193(4):181-7. PubMed ID: 14593476
[TBL] [Abstract][Full Text] [Related]
8. Pilot study on biocompatibility of fluorescent nanodiamond-(NV)-Z~800 particles in rats: safety, pharmacokinetics, and bio-distribution (part III).
Barone FC; Marcinkiewicz C; Li J; Sternberg M; Lelkes PI; Dikin DA; Bergold PJ; Gerstenhaber JA; Feuerstein G
Int J Nanomedicine; 2018; 13():5449-5468. PubMed ID: 30271140
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs.
Locher S; Schweneker M; Hausmann J; Zimmer G
J Gen Virol; 2018 Jul; 99(7):866-879. PubMed ID: 29869979
[TBL] [Abstract][Full Text] [Related]
10. Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein.
Rodríguez-Martínez LM; Marquez-Ipiña AR; López-Pacheco F; Pérez-Chavarría R; González-Vázquez JC; González-González E; Trujillo-de Santiago G; Ponce-Ponce de León CA; Zhang YS; Dokmeci MR; Khademhosseini A; Alvarez MM
PLoS One; 2015; 10(10):e0135859. PubMed ID: 26489048
[TBL] [Abstract][Full Text] [Related]
11. Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
Anderson MS; Niemuth NA; Sabourin CL; Badorrek CS; Bounds CE; Rudge TL
PLoS One; 2020; 15(8):e0238196. PubMed ID: 32841291
[TBL] [Abstract][Full Text] [Related]
12. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
[TBL] [Abstract][Full Text] [Related]
13. Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus.
DeMers HL; He S; Pandit SG; Hannah EE; Zhang Z; Yan F; Green HR; Reyes DF; Hau D; McLarty ME; Altamura L; Taylor-Howell C; Gates-Hollingsworth MA; Qiu X; AuCoin DP
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008817. PubMed ID: 33141837
[TBL] [Abstract][Full Text] [Related]
14. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
[TBL] [Abstract][Full Text] [Related]
15. A rapid point-of-care test for dengue virus-1 based on a lateral flow assay with a near-infrared fluorescent dye.
Chen L; Wang H; Guo T; Xiao C; Liu L; Zhang X; Liu B; Li P; Liu A; Li B; Li B; Mao Y
J Immunol Methods; 2018 May; 456():23-27. PubMed ID: 29454740
[TBL] [Abstract][Full Text] [Related]
16. Production and Characterization of Monoclonal Antibodies Against Gp Protein of Ebola Virus.
Yu M; Ye J; Cao S; Liu X; Chen Z
Monoclon Antib Immunodiagn Immunother; 2020 Feb; 39(1):12-16. PubMed ID: 32004438
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
18. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.
Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R
Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425
[TBL] [Abstract][Full Text] [Related]
19. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
Yu DS; Weng TH; Shen L; Wu XX; Hu CY; Wang FXC; Wu ZG; Wu HB; Wu NP; Li LJ; Yao H
Cell Physiol Biochem; 2018; 50(3):1055-1067. PubMed ID: 30355918
[TBL] [Abstract][Full Text] [Related]
20. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.
Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M
J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
